The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

Preventing thromboembolic events, while minimizing bleeding risks, remains challenging when managing patients with atrial fibrillation (AF). Several factors contribute to current dosing patterns of nonvitamin K antagonist oral anticoagulants (NOACs), including patient characteristics, comorbidities,...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyer-Westendorf, Jan, Fay, Matthew, Amara, Walid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382498/
https://www.ncbi.nlm.nih.gov/pubmed/34435170
http://dx.doi.org/10.1055/s-0041-1731777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382498/
https://www.ncbi.nlm.nih.gov/pubmed/34435170
http://dx.doi.org/10.1055/s-0041-1731777

Ejemplares similares